Literature DB >> 1676780

Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis.

Z Borok1, R Buhl, G J Grimes, A D Bokser, R C Hubbard, K J Holroyd, J H Roum, D B Czerski, A M Cantin, R G Crystal.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterised by alveolar inflammation, exaggerated release of oxidants, and subnormal concentrations of the antioxidant glutathione in respiratory epithelial lining fluid (ELF). Glutathione (600 mg twice daily for 3 days) was given by aerosol to 10 patients with IPF. Total ELF glutathione rose transiently, ELF oxidised glutathione concentrations increased, and there was a decrease in spontaneous superoxide anion release by alveolar macrophages. Thus, glutathione by aerosol could be a means of reversing the oxidant-antioxidant imbalance in IPF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676780     DOI: 10.1016/0140-6736(91)90350-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

Review 1.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 2.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 3.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

Review 4.  Antioxidants in neonatal lung disease.

Authors:  C H Fardy; M Silverman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

Review 5.  Oxidants/antioxidants in idiopathic pulmonary fibrosis.

Authors:  W MacNee; I Rahman
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

6.  Scavenging of reactive oxygen species by letosteine, a molecule with two blocked-SH groups. Comparison with free-SH drugs.

Authors:  B Gressier; N Lebegue; C Brunet; M Luyckx; T Dine; M Cazin; J C Cazin
Journal:  Pharm World Sci       Date:  1995-05-26

Review 7.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 8.  Dyskeratosis congenita, stem cells and telomeres.

Authors:  Michael Kirwan; Inderjeet Dokal
Journal:  Biochim Biophys Acta       Date:  2009-02-07

Review 9.  Oxidative stress and pulmonary fibrosis.

Authors:  Paul Cheresh; Seok-Jo Kim; Sandhya Tulasiram; David W Kamp
Journal:  Biochim Biophys Acta       Date:  2012-12-05

Review 10.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.